Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Change in Inventory (2019 - 2025)

Historic Change in Inventory for Sanofi (SNYNF) over the last 6 years, with Q4 2025 value amounting to -$45.4 million.

  • Sanofi's Change in Inventory rose 9109.28% to -$45.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.5 billion, marking a year-over-year decrease of 372.29%. This contributed to the annual value of -$44.1 million for FY2025, which is 9146.31% up from last year.
  • Per Sanofi's latest filing, its Change in Inventory stood at -$45.4 million for Q4 2025, which was up 9109.28% from -$509.7 million recorded in Q4 2024.
  • Sanofi's Change in Inventory's 5-year high stood at $16.0 million during Q4 2021, with a 5-year trough of -$931.8 million in Q4 2023.
  • Moreover, its 4-year median value for Change in Inventory was -$277.6 million (2025), whereas its average is -$367.7 million.
  • As far as peak fluctuations go, Sanofi's Change in Inventory surged by 11665.54% in 2021, and later soared by 4529.52% in 2024.
  • Quarter analysis of 4 years shows Sanofi's Change in Inventory stood at $16.0 million in 2021, then plummeted by 5917.85% to -$931.8 million in 2023, then skyrocketed by 45.3% to -$509.7 million in 2024, then surged by 91.09% to -$45.4 million in 2025.
  • Its last three reported values are -$45.4 million in Q4 2025, -$509.7 million for Q4 2024, and -$931.8 million during Q4 2023.